Operating Expenses
Variable Lease Cost
Vertex Pharmaceuticals Variable Lease Cost remained flat by 0.0% to $12.53M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 14.9%, from $10.90M to $12.53M. Over 2 years (FY 2023 to FY 2025), Variable Lease Cost shows an upward trend with a 6.0% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026
Metric ID:
unp_variable_lease_costHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $44.60M | $43.60M | $50.10M |
| YoY Change | — | -2.2% | +14.9% |
Range$43.60M – $50.10M
CAGR+6.0%
Avg YoY Growth+6.3%
Median YoY Growth+6.3%
Variable Lease Cost at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's variable lease cost?
- Vertex Pharmaceuticals (VRTX) reported variable lease cost of $12.53M in Q4 2025.
- How has Vertex Pharmaceuticals's variable lease cost changed year-over-year?
- Vertex Pharmaceuticals's variable lease cost increased by 14.9% year-over-year, from $10.90M to $12.53M.
- What is the long-term trend for Vertex Pharmaceuticals's variable lease cost?
- Over 2 years (2023 to 2025), Vertex Pharmaceuticals's variable lease cost has grown at a 6.0% compound annual growth rate (CAGR), from $44.60M to $50.10M.